ABT — Abbott Laboratories Share News
0.000.00%
Last trade - 00:00- $190.39bn
- $217.85bn
- $44.33bn
Abbott's Q3 revenue slightly beats estimates, reaffirms adjusted EPS guidance
Abbott cuts 2026 sales growth view, plans to spin off nutrition business (updated)
Brief: Abbott Announces Its Intention To Separate Its Global Nutrition Business Into An Independent, Publicly Traded Company
Abbott lowers 2026 sales growth forecast on medical device weakness
Abbott to separate global nutrition business
US STOCKS-Nasdaq futures lead gains as SpaceX, Super Micro results lift AI trade
Brief: Abbott's Cologuard Plus Receives CE Mark For Colorectal Cancer Screening In Europe
Live Markets: Dot-com deja vu? Why Goldman Sachs is calling time on the momentum trade
Advisory: Alert incorrectly tagged to Abbott Laboratories withdrawn
Medical device makers slip in sympathy with J&J's MedTech miss
MedTech growth concerns likely to overshadow Q3 results, Leerink says
Brief: Abbott Receives FDA Approval For New Cardiomems Hf System Capabilities That Help Patients Engage In The Care Of Their Heart Condition
Grail's cancer blood test nears landmark FDA approval, but insurance coverage looms
Factbox: US companies face rise in cyber attacks
Brief: Abbott And Berry Street Partner To Expand Personalized Nutrition Support For Consumers Seeking Better Metabolic Health
Grail rallies as FDA staff flags no major concerns for multi-cancer test
Brief: Abbott Declares Qtrly Common Dividend Of $0.63 Per Share
Abbott to pay $384 million over contaminated infant formula allegations, US Justice Dept says (updated)
Brief: Abbott agrees to DOJ settlement over 2022 infant formula recall